Synergy Pharmaceuticals Inc fka SGYPQ

[Snackman]

Form 8-K for SYNERGY PHARMACEUTICALS, INC.

22-Dec-2016

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events.

On December 22, 2016, Synergy Pharmaceuticals Inc. (the "Company") issued a press release announcing positive top-line results from the second of two pivotal phase 3 clinical trials evaluating the efficacy and safety of plecanatide, an investigational once-daily orally-administered compound, in 1,054 adult patients with irritable bowel syndrome with constipation (IBS-C).

The press release is attached as Exhibit 99.1 to this report on Form 8-K and is incorporated herein by reference.



Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1 Synergy Pharmaceuticals Inc. Press Release dated December 22, 2016.